Arkolith/Insider Trading/CLSD/Form 4

Lasezkay George M

CEO, DirectorClearside Biomedical, Inc. (CLSD) · full profile →Form 4 · filed Jan 20, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$23K
Net Open-Market Flow
-$23K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 19, 2022Sell(S)11K$2.12$23K505K
Jan 18, 2022Grant(A)98K—$0515K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 18, 2022Grant(A)293K—$0293K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-004191) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML